These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 15289449

  • 1. Glutathione depletion up-regulates Bcl-2 in BSO-resistant cells.
    D'Alessio M, Cerella C, Amici C, Pesce C, Coppola S, Fanelli C, De Nicola M, Cristofanon S, Clavarino G, Bergamaschi A, Magrini A, Gualandi G, Ghibelli L.
    FASEB J; 2004 Oct; 18(13):1609-11. PubMed ID: 15289449
    [Abstract] [Full Text] [Related]

  • 2. Oxidative upregulation of Bcl-2 in healthy lymphocytes.
    Cristofanon S, Nuccitelli S, D'Alessio M, Radogna F, De Nicola M, Bergamaschi A, Cerella C, Magrini A, Diederich M, Ghibelli L.
    Ann N Y Acad Sci; 2006 Dec; 1091():1-9. PubMed ID: 17341597
    [Abstract] [Full Text] [Related]

  • 3. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
    Armstrong JS, Steinauer KK, Hornung B, Irish JM, Lecane P, Birrell GW, Peehl DM, Knox SJ.
    Cell Death Differ; 2002 Mar; 9(3):252-63. PubMed ID: 11859408
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte growth factor protects RPE cells from apoptosis induced by glutathione depletion.
    Jin M, Yaung J, Kannan R, He S, Ryan SJ, Hinton DR.
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4311-9. PubMed ID: 16249513
    [Abstract] [Full Text] [Related]

  • 5. The selection between apoptosis and necrosis is differentially regulated in hydrogen peroxide-treated and glutathione-depleted human promonocytic cells.
    Troyano A, Sancho P, Fernández C, de Blas E, Bernardi P, Aller P.
    Cell Death Differ; 2003 Aug; 10(8):889-98. PubMed ID: 12867996
    [Abstract] [Full Text] [Related]

  • 6. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells.
    Friesen C, Kiess Y, Debatin KM.
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S73-85. PubMed ID: 15105835
    [Abstract] [Full Text] [Related]

  • 7. alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species.
    Brozovic A, Majhen D, Roje V, Mikac N, Jakopec S, Fritz G, Osmak M, Ambriovic-Ristov A.
    Mol Pharmacol; 2008 Jul; 74(1):298-306. PubMed ID: 18441044
    [Abstract] [Full Text] [Related]

  • 8. Regulation of apoptosis/necrosis execution in cadmium-treated human promonocytic cells under different forms of oxidative stress.
    Sancho P, Fernández C, Yuste VJ, Amrán D, Ramos AM, de Blas E, Susin SA, Aller P.
    Apoptosis; 2006 May; 11(5):673-86. PubMed ID: 16532269
    [Abstract] [Full Text] [Related]

  • 9. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
    Lewis-Wambi JS, Kim HR, Wambi C, Patel R, Pyle JR, Klein-Szanto AJ, Jordan VC.
    Breast Cancer Res; 2008 May; 10(6):R104. PubMed ID: 19061505
    [Abstract] [Full Text] [Related]

  • 10. Development of resistance to glutathione depletion-induced cell death in CC531 colon carcinoma cells: association with increased expression of bcl-2.
    Vahrmeijer AL, Hoetelmans RW, Mulder GJ, Schutrups J, van Vlierberghe RL, van de Velde CJ, van Dierendonck JH.
    Biochem Pharmacol; 2000 Jun 15; 59(12):1557-62. PubMed ID: 10799652
    [Abstract] [Full Text] [Related]

  • 11. Oxidative, multistep activation of the noncanonical NF-kappaB pathway via disulfide Bcl-3/p50 complex.
    Cristofanon S, Morceau F, Scovassi AI, Dicato M, Ghibelli L, Diederich M.
    FASEB J; 2009 Jan 15; 23(1):45-57. PubMed ID: 18796561
    [Abstract] [Full Text] [Related]

  • 12. Lack of mitochondrial depolarization by oxidative stress is associated with resistance to buthionine sulfoximine in acute lymphoblastic leukemia cells.
    Goto H, Yanagimachi M, Kajiwara R, Kuroki F, Yokota S.
    Leuk Res; 2007 Sep 15; 31(9):1293-301. PubMed ID: 17306873
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of glutathione synthesis overcomes Bcl-2-mediated topoisomerase inhibitor resistance and induces nonapoptotic cell death via mitochondrial-independent pathway.
    Yoshida A, Takemura H, Inoue H, Miyashita T, Ueda T.
    Cancer Res; 2006 Jun 01; 66(11):5772-80. PubMed ID: 16740716
    [Abstract] [Full Text] [Related]

  • 14. Effects of glutathione depletion on cadmium-induced metallothionein synthesis, cytotoxicity, and proto-oncogene expression in cultured rat myoblasts.
    Shimizu M, Hochadel JF, Waalkes MP.
    J Toxicol Environ Health; 1997 Aug 29; 51(6):609-21. PubMed ID: 9242231
    [Abstract] [Full Text] [Related]

  • 15. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
    Anderson CP, Reynolds CP.
    Bone Marrow Transplant; 2002 Aug 29; 30(3):135-40. PubMed ID: 12189530
    [Abstract] [Full Text] [Related]

  • 16. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC.
    Cancer Res; 1993 May 01; 53(9):2066-70. PubMed ID: 8097674
    [Abstract] [Full Text] [Related]

  • 17. Glutathione homeostasis in human hepatic cells: overexpression of gamma-glutamylcysteine synthetase gene in cell lines resistant to buthionine sulfoximine, an inhibitor of glutathione synthesis.
    Tanaka T, Uchiumi T, Kohno K, Tomonari A, Nishio K, Saijo N, Kondo T, Kuwano M.
    Biochem Biophys Res Commun; 1998 May 19; 246(2):398-403. PubMed ID: 9610371
    [Abstract] [Full Text] [Related]

  • 18. Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes.
    Celli A, Que FG, Gores GJ, LaRusso NF.
    Am J Physiol; 1998 Oct 19; 275(4):G749-57. PubMed ID: 9756506
    [Abstract] [Full Text] [Related]

  • 19. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
    Ramos AM, Aller P.
    Biochem Pharmacol; 2008 May 15; 75(10):1912-23. PubMed ID: 18359480
    [Abstract] [Full Text] [Related]

  • 20. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
    Yang B, Keshelava N, Anderson CP, Reynolds CP.
    Cancer Res; 2003 Apr 01; 63(7):1520-6. PubMed ID: 12670899
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.